Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

St. Jude Medical (STJ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart


See More
  • Market Capitalization, $K 23,054,430
  • Shares Outstanding, K 285,590
  • Annual Sales, $ 5,541 M
  • Annual Income, $ 880 M
  • 36-Month Beta 1.23
  • Price/Sales 3.87
  • Price/Book 5.14
  • Price/Earnings ttm 20.32
  • Earnings Per Share ttm 3.97
  • Most Recent Earnings 0.99 on 10/19/16
  • Annual Dividend & Yield 1.24 (1.54%)
  • Most Recent Dividend 0.31 on 09/28/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
78.59 +2.84%
on 12/07/16
81.31 -0.60%
on 01/04/17
+1.80 (+2.28%)
since 12/02/16
77.32 +4.53%
on 11/03/16
81.53 -0.87%
on 10/10/16
+0.99 (+1.24%)
since 10/04/16
48.83 +65.51%
on 02/11/16
84.00 -3.79%
on 08/08/16
+20.42 (+33.81%)
since 01/04/16

Most Recent Stories

More News
St. Jude's Critical Care Unit Receives National Honor

The American Association of Critical-Care Nurses awarded St. Jude Medical Center the Beacon Award for Excellence for its exemplary care to critically ill patients and families. The award distinguishes...

Abbott Completes the Acquisition of St. Jude Medical

Abbott announced today it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides Abbott with expanded opportunities...

IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600

S&P MidCap 400 constituent IDEXX Laboratories, Inc. (NASD: IDXX) will replace St. Jude Medical, Inc. (NYSE: STJ) in the S&P 500, S&P SmallCap 600 constituent The Chemours Company (NYSE: CC) will replace...

Abbott Labs to Close St. Jude Acquisition Later this Week

Abbott Laboratories (ABT) announced to close the acquisition of St. Jude Medical, Inc., (STJ) on Jan 4, 2017.

Abbott to Sell 2 Medical Device Businesses for St. Jude Buyout

Abbott Laboratories (ABT) has agreed to divest two medical device businesses in order to settle Federal Trade Commission (FTC) charges in relation to its proposed acquisition of St. Jude Medical (STJ)....

Cardiac Rhythm Management Devices Batteries Market to Worth US$518.4 Million by 2024: Improved Power Sources Ensure Swift Uptake, says TMR

Transparency Market Research states that the competitive landscape in the Global Cardiac Rhythm Management Devices Batteries Market is mildly fragmented. The leading players such as Medtronic, Boston Scientific...

Blog Coverage St Jude Medical Receives FDA Clearance for its Cardiac Mapping System

Upcoming AWS Coverage on ZELTIQ Aesthetics Post-Earnings Results

St. Jude Medical (STJ): EnSite Precision Gets FDA Clearance

St. Jude Medical Inc. (STJ), a leading global medical device manufacturer, recently announced U.S. FDA approval for the EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter....

St. Jude Medical Announces FDA Clearance of EnSite Precision Cardiac Mapping System

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA clearance of its EnSite Precision(TM) cardiac mapping system and Advisor(TM) FL Circular Mapping...

St. Jude Medical: Proclaim Elite SCS System Now CE Marked

St. Jude Medical Inc. (STJ), a leading global medical device manufacturer recently announced the CE mark approval for the full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology...

See More

Support & Resistance

2nd Resistance Point 81.54
1st Resistance Point 81.18
Last Price 80.82
1st Support Level 80.59
2nd Support Level 80.36

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.